47 filings
8-K
AERI
Aerie Pharmaceuticals Inc
13 Dec 19
Regulation FD Disclosure
6:31am
8-K
AERI
Aerie Pharmaceuticals Inc
3 Dec 19
Regulation FD Disclosure
6:31am
8-K
AERI
Aerie Pharmaceuticals Inc
3 Dec 19
Regulation FD Disclosure
6:30am
8-K
AERI
Aerie Pharmaceuticals Inc
21 Nov 19
Regulation FD Disclosure
6:41am
8-K
AERI
Aerie Pharmaceuticals Inc
18 Nov 19
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma, S.L. to Advance its Dry Eye Program
6:41am
8-K
43qbou4r
18 Nov 19
Regulation FD Disclosure
6:33am
8-K
7np5as4 1lnzs
6 Nov 19
Regulation FD Disclosure
4:10pm
8-K
hlw9pyc 6gc1
6 Nov 19
Aerie Pharmaceuticals Reports Third Quarter 2019
4:04pm
8-K
qac6kj4jfvjm 4iy
6 Nov 19
Regulation FD Disclosure
4:04pm
8-K
2f5s2
5 Nov 19
Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil Ophthalmic Solution in Phase 2 Study Conducted in Japan
6:40am
8-K
a0566cn8h4 68
24 Oct 19
Regulation FD Disclosure
6:43am
8-K
qp8cbbcb0d7nea73du1
10 Oct 19
Regulation FD Disclosure
4:02pm
8-K
bb6b9jg
2 Oct 19
Regulation FD Disclosure
7:05am
8-K
xnxhg71ho0xute shkx
20 Sep 19
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa® in the European Union
6:40am
8-K
hqw0p irmffl
19 Sep 19
Regulation FD Disclosure
6:44am
8-K
uoo2iy0mxbqa6yqxo8
13 Sep 19
Entry into a Material Definitive Agreement
5:05pm
8-K
jn6t9j3
11 Sep 19
Other Events
6:10am
8-K
kir4be4lqi
10 Sep 19
Entry into a Material Definitive Agreement
5:19pm
8-K
juozqcums9du00 lj7ig
10 Sep 19
Regulation FD Disclosure
6:32am
8-K
3b0zge0zdfuq
5 Sep 19
Regulation FD Disclosure
6:31am